Welcome to LookChem.com Sign In|Join Free
  • or
2H-Imidazol-2-one, 1,3-dihydro-1,4-diphenyl- is an organic compound with the chemical formula C15H13N2O. It is a derivative of imidazolone, featuring a diphenyl group attached to the 1,4-positions of the imidazole ring. 2H-Imidazol-2-one, 1,3-dihydro-1,4-diphenyl- is known for its potential applications in pharmaceuticals and as a building block in the synthesis of various heterocyclic compounds. It is characterized by its unique structure, which includes a five-membered imidazole ring fused to a carbonyl group, and two phenyl rings attached to adjacent positions on the imidazole. The compound's properties, such as its reactivity and stability, are influenced by the presence of these functional groups and the aromatic nature of the phenyl rings.

2032-07-7

Post Buying Request

2032-07-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2032-07-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2032-07-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,3 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2032-07:
(6*2)+(5*0)+(4*3)+(3*2)+(2*0)+(1*7)=37
37 % 10 = 7
So 2032-07-7 is a valid CAS Registry Number.

2032-07-7Downstream Products

2032-07-7Relevant academic research and scientific papers

Effect of structural modification of the hydrantoin ring on anticonvulsant activity

Cortes,Liao,Watson,Kohn

, p. 601 - 606 (1985)

Selectively substituted hydantoins (15 examples), 4-hydroxy-2-imidazolidinones (13 examples), 2-imidazolones (10 examples), 2-imidazolidinones (four examples), vicinal diamines (two examples), and simple amino acid derivatives (four examples) have been pr

T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES

-

Page/Page column 30; 33, (2008/12/07)

The present invention relates to compounds of formula IA or IB. The present invention also concerned to a method of treating immunologic diseases or pathological conditions in association with T cell involving an immunologic component using T-cell inhibitors, optionally in combination with one or more other drugs selected from steroids, DMARDs, NSAIDs, immunosuppressive, and biological modifiers, pharmaceutical compositions comprising said compounds of formula IA or IB together with said other drugs, and the use of T-cell inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2032-07-7